En Es
Categories

Industry News

Global POC Infectious Disease Market to Reach USD 1.9 Billion by 2025

By Labmedica International staff writers
09 Jan 2018

Image: The global point-of-care infectious disease diagnostics/testing market is expected to reach USD 1.90 billion by 2025 (Photo courtesy of iStock).The global point-of-care (POC) infectious disease diagnostics/testing market is expected to reach USD 1.90 billion by 2025, as the emerging trend of patient-centric services and increase in complicated infectious disorders drives an upsurge in the demand for portable and accurate detection devices.

These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.

Portable devices with the potential to enable rapid detection of infectious diseases are revolutionizing patient care and driving the growing demand for decentralized testing settings. Additionally, increased R&D investments for the development of new products are expected to further drive the POC infectious disease diagnostics/testing market. For instance, an EU project research team has developed a new lab-on-a-disc' technology that aids in the diagnosis of various infectious diseases, including malaria. Through POC treatment, the technology enables faster diagnosis and allows precise administration of drugs, thereby driving its adoption.

HIV POC is estimated to account for the largest share of the POC infectious disease diagnostics/testing market due to the rising incidence rate of the disease. Companies are also adopting a quality management approach towards the introduction of novel tests for HIV diagnosis. TB and drug resistant TB are anticipated to witness lucrative demand over the coming years on account of their rising incidence rate, fueled further by the implementation of fully or partially integrated nano/microscale technologies for developing drug resistant TB diagnostic devices.

The demand for the development of inexpensive, rapid, simple, and accurate tests capable of simultaneously detecting multiple biomarkers is expected to contribute to the market growth. Moreover, advances in bio sensing technology for early detection with sensitivity are expected to drive revenue for the market players over the coming years.

Geographically, North America dominates the global market for POC infectious disease diagnostics/testing, due to adequate administration support, well-established healthcare framework, and extensive R&D upgradation in the region. However, the Asia Pacific market is expected to record the fastest growth over the forecast period due to the rising incidence and prevalence rates of infectious diseases in the region as well as favorable government support.

Related Links:
Research and Markets



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

18 Jan 2018
Siemens Healthineers Strategy 2025 to Focus on AI
Siemens Healthineers has laid out its strategy to bolster its market leadership by 2025 and beyond, aimed at accelerating profitable growth and delivering return. The company has stated that it is well prepared to take advantage of the paradigm shift and structural growth opportunities in healthcare.
Read More
16 Jan 2018
GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform
GE Healthcare and Roche have entered into a strategic, long-term partnership to jointly develop and co-market digital clinical decision support solutions. Initially, the partnership will focus on products that accelerate and improve individualized treatment options for cancer and critical care patients.
Read More
16 Jan 2018
Global Ultrasound Market to Reach USD 6.86 Billion by 2021
The global ultrasound market is expected to grow at a CAGR of 5.2% during 2016 to 2021 to reach a value of USD 6.86 billion by 2021, driven by a growing patient population base for chronic and lifestyle-related disorders, technological advancements, and increasing demand for minimally invasive diagnostic and therapeutic techniques.
Read More
16 Jan 2018
Top Challenges for Medical Device Manufacturers in Emerging Markets
The emerging markets are expected to provide significant growth opportunities for manufacturers of medical devices due to their increasing importance in modern healthcare. In spite of the positive outlook for the emerging medical devices markets, manufacturers will need to overcome some challenges related to product quality, regulatory compliance, and data security, according to Infiniti Research, a full service business intelligence and market research firm.
Read More
16 Jan 2018
Smart Pills Market Worth USD 3 Billion by 2025
The global smart pills market was valued at USD 779.4 million in 2016 and is expected to grow at a CAGR of 15.5% during the forecast period (2017-2025) to reach USD 3.0 billion by 2025, driven by the increased prevalence of colorectal cancer and gastrointestinal disorders, geographical expansion by the major players, rising cancer screening awareness programs and faster FDA approvals.
Read More
09 Jan 2018
Seegene Develops World’s First Multiplex MDx Assays with AI System
Seegene Inc., a developer of multiplex PCR technologies, successfully developed molecular diagnostics (MDx) assays in just four days using an artificial intelligence- (AI) based automated assay development system. These assays are high multiplex real-time PCR reagents developed completely by AI and are meant for the simultaneous detection of eight different DNA targets for each of meningitis and sexually transmitted infections.
Read More
09 Jan 2018
Global Surgical Table Market Driven by Increase in Healthcare Expenditures
The global surgical table market is expected to grow at a CAGR of 2.9% from 2018 to 2023, driven by rising healthcare expenditures, increasing number of hospitals, adoption of hybrid operating rooms, and improved healthcare facilities. These are the latest findings of Research and Markets, a global market research company.
Read More
09 Jan 2018
Toshiba Medical Systems Changes Name to Canon Medical Systems
The official corporate name of Toshiba Medical Systems Corporation has been changed to Canon Medical Systems Corporation. The name change follows the completion of procedures for obtaining regulatory approval for integration with the Canon Group after the company officially became a subsidiary of Canon Inc. in December 2016. Similarly, Toshiba America Medical Systems, now a Canon group company, has been officially named as Canon Medical Systems USA, Inc.
Read More
02 Jan 2018
Fewer Pathologists and More Cancer Patients Drive Pathology Market
The global digital pathology market was worth USD 381.8 million in 2016 and is projected to grow at a CAGR of 13.2% to reach USD 708.9 million by 2021, driven by the increased adoption of digital pathology solutions worldwide due to shortage of pathologists and rise in new cancer cases. Additionally, new business models and increased FDA approvals of Whole Slide Image (WSI) scanners for primary diagnostics are expected to provide a boost to the digital pathology market.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions